Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies

The globalization of clinical trials has accelerated recent advances in multiple myeloma (MM). However, it is unclear whether trial enrollment locations are reflective of the global burden of MM and whether access to novel therapies is timely and equitable for countries that participate in those tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatoki, Raleigh Ayoolu, Koehn, Kelly, Kelkar, Amar, Al Hadidi, Samer, Mehra, Nikita, Mian, Hira, Landgren, Ola, Kazandjian, Dickran, Hoffman, James, Sborov, Douglas W., Mohyuddin, Ghulam Rehman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470137/
https://www.ncbi.nlm.nih.gov/pubmed/35960904
http://dx.doi.org/10.1200/GO.22.00119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470137/
https://www.ncbi.nlm.nih.gov/pubmed/35960904
http://dx.doi.org/10.1200/GO.22.00119

Ejemplares similares